NCT06026189 Safely Reduce Cystoscopic Evaluations for Hematuria Patients
| NCT ID | NCT06026189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Hematuria |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2023-05-31 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,100 participants in total. It began in 2023-05-31 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.
Eligibility Criteria
Inclusion Criteria: * Microscopically confirmed microscopic hematuria of voided urine defined as ≥3 erythrocytes per high power field * Male patients ≥40 years * Female patients ≥50 years Exclusion Criteria: * History of urothelial bladder- or urinary tract cancer * Presence of macroscopic (visible) hematuria * Woman who is or may be pregnant
Frequently Asked Questions
Who can join the NCT06026189 clinical trial?
This trial is open to participants of all sexes, studying Hematuria. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06026189 currently recruiting?
Yes, NCT06026189 is actively recruiting participants. Visit ClinicalTrials.gov or contact Erasmus Medical Center to inquire about joining.
Where is the NCT06026189 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06026189 clinical trial?
NCT06026189 is sponsored by Erasmus Medical Center. The trial plans to enroll 1,100 participants.